GSK

GSK plc

41.12 USD
+0.00 (+0.01%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

GSK plc stock is down -9.95% since 30 days ago. The next earnings date is Jul 24, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 58% of the previous 50 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 4 PUTs, 6 CALLs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
05 Jun 13:32 16 Aug, 2024 40.00 PUT 446 1107
05 Jun 13:57 15 Nov, 2024 41.00 CALL 150 340
05 Jun 19:40 07 Jun, 2024 42.00 CALL 1104 217
06 Jun 15:49 21 Jun, 2024 41.00 PUT 1104 246
06 Jun 15:50 28 Jun, 2024 42.00 CALL 438 170
07 Jun 14:12 21 Jun, 2024 41.00 PUT 594 3624
07 Jun 14:14 21 Jun, 2024 41.00 PUT 2906 3624
11 Jun 18:05 16 Aug, 2024 42.00 CALL 206 894
11 Jun 18:05 16 Aug, 2024 43.00 CALL 500 829
11 Jun 18:07 16 Aug, 2024 43.00 CALL 370 829

About GSK plc

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital.